According to SMS Pharmaceuticals latest financial reports the total debt is $14.50M, an decrease of -19.70% to 2022. At the end of 2022 company had $18.05M total debt. This figure represents the debts and financial obligations that SMS Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $14.50M | -19.70% |
2022 | $18.05M | 0.70% |
2021 | $17.93M | 106.25% |
2020 | $8.69M | 23.81% |
2019 | $7.02M | - |